conference for and Good Penumbra's Dan. leadership year future you and growth a a tremendous exceptional great capped XXXX quarter for you, afternoon positioning in year-end progress fourth our had made joining strong company thank toward Equally impact. success. quarter important, of we patient Thank XXXX call. and fourth and Penumbra which
resulted which year, business strong United States the in sequential to growth difficult international in quarter particularly double-digit Neuro the volumes. of fourth procedural fourth in for period of as same million from revenues XXXX We fourth of fourth quarter quarter $XXX.X million the $X.X increase the In quarter had total due In comparisons, growth stroke revenue Neuro quarter, million, saw reported ischemic growth sequential the strongest for XXXX. year. markets. income Our in were an operating our to last our the year-over-year the of saw exceptional compared we $X.X against strong our XX.X% of
Neuro. opportunity if Penumbra not vascular met our larger forward an our for in business, seeing for addition, In launch Since JET meaningful and continued as has very to the has our feedback expectations. overall physician our Engine important followed is growth our market In be we could positive be step franchise. Penumbra been September, are has which view this an high that large
new quarterly adding exceptional momentum specialist calls recall new our continued As our new to to may patient contribute markets.Both and technology technology two have these to last physicians to of discussed and efforts our growth. you in we approach bringing
also growing embolization blood the as a We use adoption we're remove seeing of procedures. growing powerful embolization Indigo of are across seeing system our tool a System platform as our number and clots a of to
This quarter embolization in we of products Japan. with expanded geographically introduction our the peripheral
this a his in in Neuro While not strategic a growth, this between remarks. our is in will in establishing our step will this and franchise divisions. this new Sri initially, shift result overall impact revenue will further forward cover in Japan vascular but
also believe success in in would will our look like and to and beyond. XXXX the at commentary, what to year to I review my lead growth we and will full XXXX Now led our share I business continued what our
steadily of For year, year increase the estimate XXXX. full clot and performed. of an reach year further involving clot year, Diseases arteries. even full year legs. We new numbers the brain from their our remove non-GAAP we effectively patients can revenues expanded we help income million to United we beyond lead reported to majority GAAP the complications, of XX.X% full in in the million, reach grew serious income were operating million the coronary the total interventions can compared more $XX address arms $XXX.X also stroke XXXX, $X.X XXXX. operating all a mortality. had as the to is often technology major XXXX, full and in body used products introduced stroke including to physicians of the Throughout physicians Penumbra The for are States, our impact be growing. In patients in with last and clot Late they our with
business three it impact, that of focus continue our allowed in accelerate hard meaningful XXXX. to are our proud to to critical We to are areas. on patient elements work and There motivates us growing
markets, and our innovation ability to Our strong and areas. new patient develop our
opportunities. we into move we will invest these continue As XXXX in and beyond, to
were XXXX, more estimate patients to ischemic be in with the at last market we between critical patients treated year. about in first thrombectomy our the we growth XXXX. XX,XXX XX,XXX saw markets.We in than end States, rapid that element, to United Looking estimate In mechanical patient stroke XX,XXX which
earlier year We treatment being estimate be of continues The has about explore growth XX patients in further stronger States, patient We foundation with believe mount well. are with added interventional we Conference, stroke clinical to greater been expanded addressable it evidence as rapid hours before. more studies uptake potentially of see Stroke outcomes. the treated groups, showing area of the see important, those can to application field United patients continues for for this earlier stroke treatment. large than encouraged now which month, to future as discussed within the year in of At this that those favorable strokes. But mechanical International such thrombectomy. held the market a was XXX,XXX the also a the last evidence potential damage have treated and mechanical strokes, roughly that The larger thrombectomy or podium of we tissue presentations benefit XXX,XXX actively core ever
nurses, physicians place They're seeing this is the and We tireless The the momentum ensure as are investments the make and They and be driver can efforts possible. procedure quickly happen be their stroke gaining impactful? systems to be to in to brought for individuals transformation and each technology day. treatment. compelling many and patients to remarkable one that their every treated are commend of infrastructure this We of increasingly surgeons. hospital that in their most coordinators of thousands difference people personnel What continue those stroke from is of stroke efforts communities. the makers encouraged patients how right all about core the making as to EMS of in
We we it normalized believe see would to XXXX. treatment greater is year. as levels more in we to possible While expect procedure growth growth did in last see of
are to clot meaningful Vascular progress just year, Over Colorado, is And that get not million longer interest market, pathways. of are to recognized, form for Florida, tremendous their have around initiative or impact. to generally but where help are New with were a of States types different a a in maceration challenge some in to Massachusetts, stroke I in Ohio center patient legislative more issued ahead thrombectomy similar have serious Efforts but form of moment like Many we week, past dissolution. some treated. states X a these and people clot resolutions, stroke and are estimate from being Penumbra very of showing people have our We hospitals to each it see thrombectomy. year the bodies. treatments each be die either to are from over also stroke the developed in to patients term with increase effective. getting the improve care take been to in XXX,XXX initiatives. or United effect turn bodies. the well similar, the clot there XXX,XXX many clot past treated ability About like body also protocols law attention intent these or Virginia related people many year or tPA a actions. change. of and for leads campaign complications. Arizona, and pain Diseases their at right than last the in would In or their people to year Tennessee, clot awareness that and is York suffer served another meaningful to considering of
our company. her System. DVT. in the just asked benefit the is and this son thrombosis growing had She started recovering with in five Nauman other removal or both when it and and patient successful hospital. dedicated huge with the clot on one swollen, causing was have order deep was extremely given the for our decided radiology removing procedure, have additional legs our of to using removed large cannot last because the the the after The our to of Nauman share Indigo surgery.Her Right to be patient be demonstrates procedure We of avoid vein impact This see advanced amount of patient and Indigo the well. brief I'd due clot hospital, became like the very leg of a as In DVT. to relieve to story tPA worse still done who surgery patient swelling clot recent technician treat if developing unrelated System the interventional the leg contribution complications Dr. the techniques a suite Dr. DVT. business years to area, to we that
turned days was out leg the it several later, not necessary. treating second As
it System have this with a great a clot to more routine, clot of ability from the suffering patients in of As parts help type of removal number significant the treat body. becomes more and will Indigo all
has allowed our element advanced several launched we accelerate The our and that innovation. products vascular business to significant critical franchises. developed have second XXXX, designed, and that is neuro
a innovate business. as have pace, rapid to at continued even we our have We scaled
more and the the provide deal are innovative professionals known affectionately We to many development great of markets. dedicated talented, Penumbra in all most believe now patient years. of products across business. have can will patients a enable in as our at significant the development in the advances for more and I Penumbra that at Their future for work we confidence continue our team future Pengineers and prolific
The is third to critical element develop that new has to our ability business areas. contributed our
last geographies. and new by the have added Over drivers new our expanding additional business to markets year, into we patient
We built our grow and foundation the and business beyond. new have areas into XXXX for business strengthened core to
backgrounds. of profound immense of employees and part company with to throughout Penumbra. pleasure personally the me of people visit has the and with the most the with, I had XXXX have work travel all been Finally, ages for
in future. past call anything from deep execute the year, we now medical we suffering the people ways, sights me continue a remain review to we I've I'll confident on. achieve well number the will and great our over can team and contribute I the conditions into set serious Over to to that our Sri this turn watched confidence of that extraordinary help financials. gives
